Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
American Radiolabeled Chemicals supplies over 4,500–5,000 radiolabeled and unlabeled chemicals globally for life science research. Their catalog includes carbon‑14 and tritium-labeled compounds as well as custom synthesis services. They are considered the second-largest global supplier of radiochemicals after PerkinElmer. Their products support pharmaceutical R&D including FDA-mandated safety studies such as ADME.
The company does not develop therapeutics or conduct clinical trials.
Sales have grown steadily at about 5–10% per year in recent years.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on American Radiolabeled Chemicals.